通过循环素依赖性激酶抑制剂 (CDKI) 进行癌症治疗:从长椅到床边
Ali Hassanzadeh1, Navid Shomali2,3, Amin Kamrani2,3
1Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
EXCLI journal
|July 10, 2024
概括
用循环素依赖激酶 (CDK) 抑制剂向细胞分裂显示出癌症治疗的前景. 组合疗法正在提高泛CDK抑制剂的安全性和有效性,使其适用于临床使用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症的特征是无法控制的细胞分裂,使得细胞循环调节者如循环林依赖激酶 (CDK) 成为关键的治疗点.
- 虽然CDK抑制剂 (CDKI) 已被批准用于某些癌症,但第一代泛CDK抑制剂由于毒性和缺乏特异性而面临挑战.
- 结合疗法的近期进展表明,有可能减轻泛CDK抑制剂的不良影响.
研究的目的:
- 审查CDK家族的成员及其在细胞循环调节中的作用.
- 为CDK抑制剂提供当前研究环境的概述.
- 突出泛-CDK抑制剂在癌症治疗的联合治疗中的新增潜力.
主要方法:
- 对CDK家族成员及其在细胞循环调节中的功能进行文献综述.
- 对各种CDK抑制剂的现有研究的审查,包括第一代泛CDK抑制剂.
- 分析涉及CDK抑制剂的组合疗法策略的近期进展.
主要成果:
- 循环素依赖激酶 (CDK) 是细胞循环的中央调节者,使它们成为癌症治疗的关键标.
- 第一代泛CDK抑制剂表现出显著的毒性和缺乏选择性,限制了它们的临床应用.
- 新兴的组合疗法方法已经成功降低了泛CDK抑制剂的毒性,提高了它们的治疗潜力.
结论:
- 全CDK抑制剂在组合疗法中使用时,为癌症治疗中的临床应用提供了新的希望.
- 对优化组合疗法的进一步研究对于最大限度地提高CDK抑制剂的有效性和安全性至关重要.
- 了解CDK家族的作用对于开发向癌症疗法至关重要.
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K


